2 results
Approved WMOCompleted
The objective of this open label phase IIa trial is to evaluate the efficacy and tolerability of a once a week dose of 200 mg R126638, for a maximum of 12 weeks, for the treatment of toenail onychomycosis.
Approved WMOCompleted
The aim of this study is to validate a clinical VLE prediction score and to develop a VLE computer algorith that could improve detection of early neoplasie in BE patients.